Cargando…
Prostate-specific antigen-based screening: controversy and guidelines
Although prostate-specific antigen (PSA) screening has improved the detection of prostate cancer, allowing for stage migration to less advanced disease, the precise mortality benefit of early detection is unclear. This is in part due to a discrepancy between the two large randomized controlled trial...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371717/ https://www.ncbi.nlm.nih.gov/pubmed/25857320 http://dx.doi.org/10.1186/s12916-015-0296-5 |